- Vaccine Name: Boostrix-Polio
- Target Pathogen: Poliovirus
- Target Disease: Polio
- Product Name: Combined diphtheria, tetanus, acellular pertussis (adsorbed) and inactivated poliomyelitis vaccine
- Tradename: Boostrix-Polio
- Manufacturer: GlaxoSmithKline
- Type: Toxoid vaccine + Subunit vaccine + Inactivated or "killed" vaccine
- Status: Licensed
- Location Licensed: Canada
- Host Species for Licensed Use: Human
- Allergen: Neomycin, Polymyxin B
- Immunization Route: Intramuscular injection (i.m.)
- Storage: Store at 2° to 8°C (35° to 46°F), do not freeze.
- Approved Age for Licensed Use: 4 years and older
- Description: BOOSTRIX®-POLIO (combined diphtheria, tetanus, acellular pertussis and inactivated poliomyetitis) vaccine contains diphtheria toxoid, tetanus toxoid, three purified pertussis antigens [pertussis toxoid (PT), filamentous haemagglutinin (FHA) and pertactin (69 kDalton outer membrane protein)] adsorbed onto aluminum salts and inactivated polio virus types 1, 2 and 3. (GSK: Boostrix-Polio)
|
